Name
premar2
Label
Premarin (Conjugated Estrogens) (SHHS2)
Description

Participant taking PREMARIN (CONJUGATED ESTROGENS) within two weeks of the SHHS2 visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Domain
noyes01
  • 0: No
  • 1: Yes
Type
choices
Tags
Premarin (Conjugated Estrogens) (SHHS2) vs SHHS Visit Number
Visit 1 Visit 2 CVD Outcomes
Total 5,804 4,080 5,042
No - 3,197 -
Yes - 423 -
Unknown 5,804 460 5,042
Premarin (Conjugated Estrogens) (SHHS2) vs Age at SHHS1
Visit 1
39.0 to 55.0 years 55.0 to 63.0 years 63.0 to 72.0 years 72.0 to 100.0 years Total
Total 1,451 1,451 1,451 1,451 5,804
No - - - - -
Yes - - - - -
Unknown 1,451 1,451 1,451 1,451 5,804
Premarin (Conjugated Estrogens) (SHHS2) vs Gender
Visit 1
Female Male Total
Total 3,039 2,765 5,804
No - - -
Yes - - -
Unknown 3,039 2,765 5,804
Premarin (Conjugated Estrogens) (SHHS2) vs Gender
Visit 2
Female Male Total
Total 2,219 1,861 4,080
No 1,537 1,660 3,197
Yes 422 1 423
Unknown 260 200 460
Premarin (Conjugated Estrogens) (SHHS2) vs Race
Visit 1
white black native amer/alaskan asian/pacific islander hispanic/mex. amer other Total
Total 4,907 515 11 88 280 3 5,804
No - - - - - - -
Yes - - - - - - -
Unknown 4,907 515 11 88 280 3 5,804
Premarin (Conjugated Estrogens) (SHHS2) vs Race
Visit 2
white black native amer/alaskan asian/pacific islander hispanic/mex. amer other Total
Total 3,587 256 8 48 180 1 4,080
No 2,776 230 5 40 145 1 3,197
Yes 386 12 1 3 21 - 423
Unknown 425 14 2 5 14 - 460